Literature DB >> 1466752

Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited.

L C Harrison1.   

Abstract

A major goal of research into IDDM has been the identification of the 'causative antigen'. As described in this article by Len Harrison, this reductionist aim is confounded by the fact that numerous candidate islet cell antigens have been described. He scrutinizes the credentials of these candidates and discusses the problem of using autoantibodies to identify causative antigens in a T-cell-mediated disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466752     DOI: 10.1016/0167-5699(92)90170-C

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  12 in total

Review 1.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

Review 2.  Antigen targets of type 1 diabetes autoimmunity.

Authors:  Bart O Roep; Mark Peakman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 3.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

Review 4.  Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

Authors:  L C Harrison
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

Review 5.  Oral tolerance.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.

Authors:  L Geng; M Solimena; R A Flavell; R S Sherwin; A C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

Authors:  G Rudy; N Stone; L C Harrison; P G Colman; P McNair; V Brusic; M B French; M C Honeyman; B Tait; A M Lew
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

8.  Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

Authors:  A Friedman; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).

Authors:  M A Payton; C J Hawkes; M R Christie
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes.

Authors:  M C Honeyman; D S Cram; L C Harrison
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.